Lexology January 30, 2023
Our handling of, and emergence from, the COVID-19 pandemic has, in no small part, been due to the many significant advances made by big tech and the life sciences sector.
For example, big tech facilitated contract-tracing and the roll-out of electronic vaccine records, the medical device sector significantly scaled-up production of much-needed ventilators and big pharma developed vaccines and treatments for the longer term.
Unsurprisingly, some of the practices that were still in their infancy before the pandemic are now commonplace: the rise of telemedicine being one such example. However, 2023 looks set to be the year that life sciences companies push even further into the domain of big tech.
In the early days of the industry, medical devices elicited...
Today's Sponsors
Today's Sponsor